01.30.23 -- Defining The RNA Therapeutics Industry In 2023

Understanding how purification columns work can help operators better conceptualize the process, enabling greater process understanding and troubleshooting.

With roughly 90% of all drugs failing to make it through clinical trials, accelerating the first step of getting to the clinic with a new mAb candidate is crucial.

This webinar reviews the impact of regulatory changes related to elemental impurities testing, guidance on the best routes to compliance, and an overview of the elemental impurities risk assessment process.

Review the critical parameters for scalable production during upstream and downstream process development, with details on achieving scalable transfection in adherent and suspension platforms.

Thanks to the long-term planning of one biopharma family and some help from the U.S. Army, a universal influenza vaccine is coming soon to a clinical trial near you.

Explore studies that highlight the benefits of prefiltration for increasing the throughput capacity of sterilizing-grade filters challenged with streams containing a wide range of particle size distributions.

An experienced contract manufacturer can help drug developers to better utilize internal resources, leverage deep industry experience, and mitigate risk across development cycles.

Taking an effective approach to cleaning equipment is paramount. Process experts share more about cleaning validation and verification, the differences between the two, and why they’re so important.

Explore the utility of electron capture dissociation (ECD) on the SELECT SERIES Cyclic IMS instrument for unambiguous assignment of glycosylation site locations for 11 Oglycopeptide species of ENBREL.

Changes in raw materials are inevitable over a drug's lifespan, but even small modifications can throw your drug out of compliance. Learn how to safeguard drug integrity when raw materials change.

Gain a more thorough understanding of single-use technology, security of supply, and business continuity management, as well as the need to take action to benefit from multisite manufacturing.

Although polymer bags are an excellent choice for cold chain use, not all polymer films perform the same way, even if their specifications rate them for use at low temperatures.